Literature DB >> 28697071

ORIF Patella Fracture With a Tension Band Construct.

Laura Blum1, Mark Hake.   

Abstract

Patellar fractures can occur as a result of direct or indirect injuries. Indirect injury is more common and occurs when the patella fails in tension when the force exerted by the extensor mechanism exceeds that of the bone. Common mechanism of indirect injury is rapid knee flexion with fully contracted quadriceps muscle. Treatment with a tension band construct is indicated for transverse patella fractures without significant comminution. This can be performed with 18-gauge wire and either 2 parallel, longitudinally oriented cannulated screws or 2 Kirschner wires. Biomechanical studies have shown higher load to failure when performed with cannulated screws. We presented our technique for management of a transverse patella fracture with disrupted extensor mechanism using tension banding technique with cannulated screws.

Entities:  

Mesh:

Year:  2017        PMID: 28697071     DOI: 10.1097/BOT.0000000000000891

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  3 in total

1.  Cannulated Screw Prominence in Tension Band Wiring of Patella Fractures Increases Fracture Gapping: A Cadaver Study.

Authors:  Matthew C Avery; Sally Jo; Andrew Chang; William M Ricci; Christopher McAndrew; Anna N Miller; Simon Tang
Journal:  Clin Orthop Relat Res       Date:  2019-05       Impact factor: 4.176

2.  A precise navigation device for fixation of patella fractures with modified K-wire tension band:a comparative retrospective study.

Authors:  Fuming Wang; Haolan Xiong; Xiaotao Long; Yang Li; Xiaohua Chen; Gang Wang
Journal:  J Orthop Surg Res       Date:  2021-02-01       Impact factor: 2.359

3.  Modified tension band wiring of patellar fracture as a technique to minimize postoperative complications: A case report.

Authors:  Tiecheng Yu; Zhendong Wu; Sayid Omar Mohamed; Weina Ju; Xiuxin Liu; Baochang Qi
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.